戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 152作成日:2026年10月23日

2,4-Dichloropyridine → 4-chloro-N-(2-methylpyrazol-3-yl)pyridin-2-amine

https://huagongshe.com/ja/reaction/152

反応式

関与物質

役割名称HCID仕込み量
反応物2,4-DichloropyridineHCID 33515—
反応物2-Methyl-2H-pyrazol-3-ylamineHCID 136927—
試薬Sodium t-butoxideHCID 23676156—
触媒1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)HCID 636044—
触媒Bis(dibenzylideneacetone)palladiumHCID 9811564—
溶媒1,4-DioxaneHCID 31275—
生成物4-chloro-N-(2-methylpyrazol-3-yl)pyridin-2-amineHCID 12143971356.88%

反応条件

温度130 °C

反応手順

TRIS(DIBENZYLIDENEACETONE)DIPALLADIUM(0) (251 mg, 0.27 mmol) was added in one portion to 2,4-dichloropyridine (1000mg, 6.76 mmol), 1,3-dimethyl-1H-pyrazol-5-amine (826 mg, 7.43 mmol), (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphine) (461 mg, 0.80 mmol) and sodium tert-butoxide (974 mg, 10.14 mmol) in 1,4-dioxane (60 mL) warmed to 130ºC over a period of 10 minutes under nitrogen. The resulting mixture was stirred at 130°C for 20 hours. The reaction mixture was evaporated to dryness and redissolved in DCM (150 mL). Solids were filtered off by suction and the filtrate subsequently washed with water (100 mL). The organic layer was dried over MgSO4, filtered and evaporated to afford crude product. The crude product was purified by flash silica chromatography, elution gradient 0 to 4% MeOH in DCM. Pure fractions were evaporated to dryness to afford 4-chloro-N-(1-methyl-1H-pyrazol-5-yl)pyridin-2-amine (802 mg, 56.9 %) as a yellow oil which crystallised on standing.

情報源と証拠

出典データセット750 AstraZeneca ELN dataset
ORD IDord-3c8e64b916074a0fa79f8b674402d3e9
出典メモ750 AstraZeneca ELN dataset